Seattle biotech AltPep closes $23M funding round for Alzheimer’s research

Matrix Capital Management of Waltham, Massachusetts, led the round. AltPep's CEO says the funding will further the company's preclinical therapeutic program.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.